CIK 0001739410
- Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851083789
- Phone
- +1 203-859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | MACKAY MARTIN Director | Exercise or conversion | +11,607 | $7.60 | $88K | 103,415 |
| 2026-11-04 | MACKAY MARTIN Director | Exercise or conversion | +3,562 | $2.38 | $8K | 106,977 |
| 2026-11-04 | MACKAY MARTIN Director | Exercise or conversion | +18,055 | $4.45 | $80K | 125,032 |
| 2026-11-04 | MACKAY MARTIN Director | Exercise or conversion · Option (Right to Buy) | −11,607 | $5.60 | $65K | 0 |
| 2026-11-04 | MACKAY MARTIN Director | Exercise or conversion · Option (Right to Buy) | −3,562 | 0 | ||
| 2026-11-04 | MACKAY MARTIN Director | Exercise or conversion · Option (Right to Buy) | −18,055 | $3.60 | $65K | 0 |
| 2026-02-18 | MACKAY MARTIN Director | Grant or award · Option (Right to Buy) | +18,055 | $3.60 | $65K | 18,055 |
| 2025-05-13 | MACKAY MARTIN Director | Grant or award · Option (Right to Buy) | +28,500 | 28,500 | ||
| 2025-01-02 | MACKAY MARTIN Director | Grant or award · Option (Right to Buy) | +92,857 | $0.70 | $65K | 92,857 |
| 2024-02-15 | MACKAY MARTIN Executive Chairman | Grant or award · Option (Right to Buy) | +216,000 | 216,000 | ||
| 2023-02-06 | MACKAY MARTIN Chief Executive Officer | Grant or award · Option (Right to Buy) | +214,000 | 214,000 | ||
| 2022-02-07 | MACKAY MARTIN Chief Executive Officer | Grant or award · Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-01-11 | MACKAY MARTIN Chief Executive Officer | Purchase | +4,496 | $10.65 | $48K | 282,609 |
| 2022-01-10 | MACKAY MARTIN Chief Executive Officer | Purchase | +5,504 | $10.10 | $56K | 278,113 |
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other acquisition | +272,609 | 272,609 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other acquisition | +436,517 | 436,517 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other disposition · Common Units | −2,255,001 | 0 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other disposition · Common Units | −2,564,999 | 0 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other disposition · Series A-1 Preferred Units | −150,000 | 0 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other disposition · Series A-2 Preferred Units | −100,000 | 0 |
Page 1 of 2 · 22 trades